Agenda - Wednesday, March 19, 2025 | Life Sciences Accounting & Reporting Congress

Wednesday, March 19, 2025Wednesday, 19 March 2025 - ET (Eastern Time, GMT-05:00)

Showing 1 of 1 Streams

Plenary

6:00am - 6:45am

Fun Run/Walk

Join industry colleagues in a morning Fun Run or Walk! Participants will meet in the Hilton Penn's Landing lobby at 6:00AM, and run just about 2 miles along the Riverwalk. All levels welcome to join!

8:00am - 8:30am

Breakfast

8:30am - 8:45am

Chairperson’s Review of Day One

8:45am - 9:45am

Controllership Panel

Fiduciary responsibilities

Ethics and compliance

Technology and its impact on accounting

Managing responsibilities and evolving duties

CPE credits available: 1.2

Dalton Smart - Senior Vice President Finance, Global Controller, Merck
Scott Godsoe - U.S. Controller, Takeda Pharmaceuticals
Rakhi Kumar - Chief Accounting Officer, Roivant Sciences
Matthew Busch - Chief Accounting Officer, Amgen
Robert Decker - VP, Corporate Controller, Chief Accounting Officer, Johnson & Johnson

9:45am - 10:30am

GEN AI 2.0

CPE credits available: 0.8

Showing 1 of 1 Streams

Break

10:30am - 11:00am

Networking Break

Showing 2 of 2 Streams

Industry Only Round Table

GTN Bootcamp

11:00am - 1:00pm

Industry Only Round Table

Stephen Rivera - Vice President, Global Technical Accounting Advisory Services & Policy, Johnson & Johnson

11:00am - 1:00pm

GTN Bootcamp

Audit SOPs for best practice methodology
Data sources
State programs
Government programs

CPE credits available: 2.4

Kinneret Klein - Executive Director, Commercial Financial Planning & Analysis, Biocryst
Anthony Casey - Principal, CIA, Baker Tilly
Matt Reierson - Consulting Senior Manager, Baker Tilly

Showing 1 of 1 Streams

Break

1:00pm - 2:00pm

Luncheon & Trail Blazer Awards

Showing 3 of 3 Streams

Mid/Large Company Track

Small/Emerging Company Track

Operational Excellence

2:00pm - 2:45pm

IRA & Government Programs

Refresher on policy updates
Challenges with new reporting procedures
Data collection origin and system management

CPE credits available: 0.8

Timothy Kocses - Executive Director, US Commercial Controller, Bristol Myers Squibb

2:50pm - 3:35pm

Implementing new reporting disclosures

DISE
Segment Reporting
Environmental Credits
Tax reporting change

ensuring sufficient documentation

Practical applications and use cases

CPE credits available: 0.8

Thomas Cunningham - Assistant Controller, Merck
Scott Doelger - Vice President, Financial Reporting and Accounting, Bristol-Myers Squibb
Marc Siegel - Former FASB and SASB Board Member, .

2:00pm - 2:45pm

Reporting systems

Process automation identification
Integration components
Optimizing resources

CPE credits available: 0.8

Tyler Mead - Senior Manager, Financial Reporting and Internal Controls, Immuneering Corporation

2:50pm - 3:35pm

Financial Considerations for Clinical Trials

Monitoring payments
Lag challenges
Scenario planning
Accruals

CPE credits available: 0.8

Jennifer Kyle - Founder and CEO, Condor Software
Christian Alaia - Senior Director, FP&A, Immuneering Corporation

2:00pm - 2:45pm

Fund Raising and Capital Allocation

New items proposed by FASB- R&D derivatives
Deal trends and considerations for partnership

CPE credits available: 0.8

Scott Raichilson - VP, Transactional and Technical Accounting, Royalty Pharma
Sean Godbout - Global Corporate Controller, Biogen

2:50pm - 3:35pm

Hiring & Team Development

Best practices and approaches to filling roles within organization
Talent retainment
Supporting licensed professionals in your organization

CPE credits available: 0.8

Laura Klein - Director, Consolidations and Financial Reporting, Bristol-Myers Squibb
Dalton Smart - Senior Vice President Finance, Global Controller, Merck

Showing 1 of 1 Streams

Break

3:35pm - 4:05pm

Networking Break

Showing 3 of 3 Streams

Mid/Large Company Track

Small/Emerging Company Track

Operational Excellence

4:05pm - 4:50pm

Audit Preparation

Cybersecurity

3rd party controls
Supporting documents

IPE
Continuous monitoring to minimize touchpoints

CPE credits available: 0.8

Robert Auslander - Vice President, Head of Internal Audit, Bausch & Lomb
Anna Simansky - VP Global Audit Services, Zimmer Biomet
Sandra Addo - Vice President, Chief Audit Executive, Merck

4:55pm - 5:40pm

Data, Systems, and Management

Insource vs. Outsource systems benefits and challenges
Cloud-based software integrations
Governance
Risk management
SOX considerations

CPE credits available: 0.8

Adam Pajakowski - Prinicpal, Crowe

4:05pm - 4:50pm

Valuations and Forecasting

Valuation model creation
DCF mode
Resources to ensure accuracy
Methods for model improvement

CPE credits available: 0.8

Robert Tantoco - Vice President of Finance, Syros Pharmaceuticals

4:55pm - 5:40pm

Accounting for Acquisitions

Collaborations, mergers, reverse mergers, M&A activity
Shifting procedures to align with parent entity
Collaboration amongst finance and accounting teams from both organizations

CPE credits available: 0.8

Meagan Caldwell - Senior Director of Technical Accounting, Sumitomo Pharma America, Inc
Jennifer Essig - Senior Director, Corporate Controller, Deciphera Pharmaceuticals

4:05pm - 4:50pm

Supply Chain and Inventory Management

Control and ownership of responsibilities
Effective tracking for optimal output

CPE credits available: 0.8

Justin Renz - Chief Financial Officer, Ardelyx

4:55pm - 5:40pm

Executive Think Tank

This open forum allows for senior level executives to exchange ideas and best practices for driving internal and organizational success through efficiencies, technology, and new innovations.

*Informa Connect reserves the right to qualify participants for this Summit. Attendees must be a Director/Senior Director/VP with 10+ years' experience and currently employed by a life sciences manufacturer.

CPE credits available: 0.8

Mallory Morales - Chief Accounting Officer, Treasurer, Immuneering Corporation
Michael Clark - Corporate Controller, Legend Biotech

Showing 1 of 1 Streams

Plenary

5:40pm - 6:40pm

Networking Reception